These products are not intended for administration to humans or animals, are not approved drugs, and are not intended for the diagnosis, treatment, cure, or prevention of any disease or medical condition
Alternate injection sites include the outer thigh or upper arm fatty tissue if rotating sites to prevent lipohypertrophy (tissue buildup from repeated injections)
Best Injectable Peptide for Weight Loss for 2026 when fat loss and tissue healing are dual goals
Retatrutide (a triple GIP/GLP-1/glucagon receptor agonist), survodutide, mazdutide, and CagriSema represent the next generation of anti-obesity compounds that may offer even greater efficacy or better tolerability profiles
These include inhalation solutions, chemotherapy, and immunosuppressive drugs
AOD 9604 helps but can't completely overcome terrible lifestyle factors